SiPhox Health, At-Home Biomarker Test
At-home blood testing across up to 60 biomarkers with a no-needle upper-arm draw - the lab panel you run from your kitchen, with AI insights and HSA/FSA coverage.
Lifespan Vault earns an affiliate commission when you buy through links on this page, at no extra cost to you. It does not change our rankings or our verdicts.
QUICK VERDICT
The at-home blood panel that skips the lab visit and the needle: a small upper-arm sample, up to 60 biomarkers, results in 7-10 days with an AI-built action plan. The lowest-friction way to actually test as often as longevity tracking wants you to.
- Best for
- Buyers who want frequent, low-friction biomarker tracking without lab visits or needles, especially anyone testing quarterly to watch trends rather than once a year. HSA/FSA users get a meaningful pre-tax discount.
- Skip if
- You want the single broadest one-time panel (Function 160+ or Mito 117 to 178 markers with clinician review), or you need an active prescribing relationship for hormones or GLP-1s - this is testing and insight only.
- Tier
- Entry
The hardest part of biomarker tracking is not the science, it is the friction: booking a lab, fasting, driving in, the draw, waiting on a portal. SiPhox removes most of it. You collect a small sample at home with their EasyDraw device (upper arm, no finger prick), mail it back, and get results across up to 60 markers - heart, metabolic, thyroid, hormones, inflammation, kidney, liver, and nutritional status - in about 7-10 days, with an AI summary and a personalized action plan on top.
Where SiPhox fits against the comprehensive platforms: Function Health (160+ markers) and Mito Health (117 to 178 by panel) run a wider panel with clinician review, and they are the right pick if you want the broadest one-time snapshot. SiPhox trades panel breadth for frequency and convenience - the no-needle at-home collection and lower entry price make it realistic to test every quarter rather than once a year, which is where biomarker tracking actually earns its value (trend lines, not single points). It is also HSA/FSA eligible, which effectively discounts it 20-37% pre-tax.
The honest framing: SiPhox is testing and insight, not a prescribing relationship. It tells you what your numbers are doing and suggests changes; it does not manage hormones or write prescriptions. For longevity buyers, the clean stack is one comprehensive annual panel (Function or Mito) plus SiPhox for cheaper, more frequent at-home check-ins between draws.
Buyers who want frequent, low-friction biomarker tracking without lab visits or needles, especially anyone testing quarterly to watch trends rather than once a year. HSA/FSA users get a meaningful pre-tax discount.
You want the single broadest one-time panel (Function 160+ or Mito 117 to 178 markers with clinician review), or you need an active prescribing relationship for hormones or GLP-1s - this is testing and insight only.
Specifications
Most often compared with
Where this fits
SiPhox Health At-Home Biomarker Test cross-shops across several editorial surfaces on this site: the full brand catalog, the buyer-intent tags this item carries, the price band it qualifies for and the in-depth guides for its category.
SiPhox Health At-Home Biomarker Test - buyer FAQ
How is SiPhox different from Function Health or Mito Health?
Breadth vs frequency. Function (160+ markers) and Mito (117 to 178 by panel) run a wider panel with clinician review - best for the broadest annual snapshot. SiPhox tests up to 60 markers but collects at home with a no-needle arm draw at a lower entry price, which makes quarterly testing realistic. The longevity-useful signal is the trend over time, so many buyers run one comprehensive annual panel plus SiPhox for cheaper check-ins between draws.
Do I need to go to a lab or get a needle draw?
No. SiPhox uses an at-home EasyDraw device that collects a small sample from your upper arm - no lab visit, no finger prick. You mail it back and results come in about 7-10 days. The first kit typically ships in 3-5 days.
Is SiPhox HSA/FSA eligible, and is it a diagnosis?
It is HSA/FSA eligible, which effectively discounts it 20-37% pre-tax. It is a testing and tracking tool, not a medical diagnosis or treatment: it reports your biomarker values and suggests lifestyle and supplement changes via an AI action plan. Anything that looks off should be reviewed with a qualified clinician.
SiPhox Health
$124 · Verified 2026-08-21 · HSA/FSA eligible per brand
Shop SiPhox Health →